CLINICAL_TRIALS
trial_result
· 2011-04-11
Clinical Trial Update: Alprostadil in Maculopathy Study (AIMS) [Phase 3]
Summary
Phase 3 trial of alprostadil for macular degeneration was terminated; results were posted on 2011-04-11.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: UCB Pharma | Conditions: Macular Degeneration | Phase 3 | Status: TERMINATED | Results posted: 2011-04-11